channelbio.com.au valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
Meta Tags
| Title | AbCellera |
| Description | The antibody discovery & development AbCellera is an antibody discovery and development engine specifically designed to break the barriers of conventional discovery and help bring new medicines to patients |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 52.25.87.207 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
channelbio.com.au Valuation
|
US$1,124
Last updated: 2023-05-10 16:29:20
channelbio.com.au has Semrush global rank of 0. channelbio.com.au has an estimated worth of US$ 1,124, based on its estimated Ads revenue. channelbio.com.au receives approximately 129 unique visitors each day. Its web server is located in United States, with IP address 52.25.87.207. According to SiteAdvisor, channelbio.com.au is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$1,124 |
| Daily Ads Revenue | US$1 |
| Monthly Ads Revenue | US$31 |
| Yearly Ads Revenue | US$373 |
| Daily Unique Visitors | 8 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| channelbio.com.au. | A | 300 | IP: 52.25.87.207 |
| channelbio.com.au. | NS | 86400 | NS Record: ns-125.awsdns-15.com. |
| channelbio.com.au. | NS | 86400 | NS Record: ns-1504.awsdns-60.org. |
| channelbio.com.au. | NS | 86400 | NS Record: ns-1738.awsdns-25.co.uk. |
| channelbio.com.au. | NS | 86400 | NS Record: ns-664.awsdns-19.net. |
| channelbio.com.au. | MX | 300 | MX Record: 10 alt4.aspmx.l.google.com. |
| channelbio.com.au. | MX | 300 | MX Record: 5 alt1.aspmx.l.google.com. |
| channelbio.com.au. | MX | 300 | MX Record: 5 alt2.aspmx.l.google.com. |
| channelbio.com.au. | MX | 300 | MX Record: 1 aspmx.l.google.com. |
| channelbio.com.au. | MX | 300 | MX Record: 10 alt3.aspmx.l.google.com. |
| channelbio.com.au. | TXT | 300 | TXT Record: MS=ms38133196 |
| channelbio.com.au. | TXT | 300 | TXT Record: ZOOM_verify_G72ppF4_RBSAhcPXR-69KA |
| channelbio.com.au. | TXT | 300 | TXT Record: google-site-verification=A17RdYjCSA75I4MLN8iyAXJuE_JpmFzN_SPFOuhWTgE |
| channelbio.com.au. | TXT | 300 | TXT Record: v=spf1 include:_spf.google.com include:_spf.trustedemail.co ~all |
HtmlToTextCheckTime:2023-05-10 16:29:20
| Team Technology Partnership News & Events Investors Contact Careers The antibody discovery & development engine Break the barriers of conventional discovery. Our discovery process --> WORK TOGETHER. WIN TOGETHER. We partner with drug developers of all sizes to push therapeutic programs forward and fight disease. When you need to move quickly and tackle the toughest problems in drug development, we’ve got your back. We’ll work closely with your team and do what it takes to deliver. Partner with us DRIVEN BY SCIENCE, FOCUSED ON PEOPLE. We believe advancing science enhances lives, and it all starts with great collaborations. We’ve built a place where people feel they are part of something bigger than themselves. A place that exists to push the limits of science and technology, and aims to bring better therapies to patients. Meet our team In The News May 4, 2023 AbCellera Reports Q1 2023 Business Results Read article April 17, 2023 AbCellera Presents New Data on T-Cell Engager Platform |
HTTP Headers
HTTP/1.1 301 Moved Permanently Content-Length: 149 Content-Type: text/html; charset=UTF-8 Location: https://channelbio.com.au/ Server: Microsoft-IIS/10.0 Access-Control-Allow-Credentials: true Access-Control-Allow-Headers: Origin, X-Requested-With, Content-Type, Accept, Set-Cookie, withCredentials, Authorization Access-Control-Allow-Origin: Date: Wed, 03 Nov 2021 02:09:51 GMT HTTP/2 200 content-type: text/html; charset=utf-8 server: Microsoft-IIS/10.0 access-control-allow-credentials: true access-control-allow-headers: Origin, X-Requested-With, Content-Type, Accept, Set-Cookie, withCredentials, Authorization access-control-allow-origin: date: Wed, 03 Nov 2021 02:09:51 GMT |